Insider Trading: Threshold Pharmaceuticals Inc (THLD.PH)
THLD.PH on Philadelphia Stock Exchange
5.42USD
22 May 2013
5.42USD
22 May 2013
Price Change (% chg)
$-0.03 (-0.55%)
$-0.03 (-0.55%)
Prev Close
$5.45
$5.45
Open
$5.37
$5.37
Day's High
$5.42
$5.42
Day's Low
$5.37
$5.37
Volume
300
300
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
All Insider Trades
| Trading Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| 11 Nov 2012 | COXE TENCH C |
Beneficial Owner of More than 10% Class | Gift | 228,310 | $0.00 |
| 11 Nov 2012 | COXE TENCH C |
Beneficial Owner of More than 10% Class | Gift | 228,310 | $0.00 |
| 10 Oct 2012 | PARKER GEORGE G C |
Director | Buy | 12,500 | $1.64 |
| 10 Oct 2012 | PARKER GEORGE G C |
Director | Sell | 22,500 | $5.65 |
| 10 Oct 2012 | PARKER GEORGE G C |
Director | Buy | 10,000 | $1.95 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 2,500 | $1.30 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 10,000 | $0.79 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 12,500 | $1.64 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 10,000 | $1.95 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 2,500 | $1.30 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 2,500 | $1.30 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 2,500 | $1.30 |
| 3 Sep 2012 | JAEGER WILFRED E |
Director | Buy | 12,500 | $1.62 |
| 26 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 14,612 | $7.98 |
| 26 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 271,788 | $7.98 |
| 23 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 474,490 | $8.02 |
| 23 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 25,510 | $8.02 |
| 23 Aug 2012 | FERNANDES JOEL A |
Officer | Sell | 9,500 | $8.10 |
| 21 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 56,610 | $7.52 |
| 21 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 2,990 | $7.52 |
| 20 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 1,531 | $7.50 |
| 20 Aug 2012 | JAEGER WILFRED E |
Director | Sell | 28,469 | $7.50 |
| 8 Aug 2012 | JAEGER WILFRED E |
Director | Buy | 397,478 | $2.05 |
| 8 Aug 2012 | JAEGER WILFRED E |
Director | Buy | 372,149 | $1.86 |
| 8 Aug 2012 | JAEGER WILFRED E |
Director | Buy | 20,007 | $1.86 |
Institutional Holders
| % Shares Owned: | 74.61% |
| # of Holders: | 125 |
| Total Shares Held: | 42,192,626 |
| 3 Mo. Net Change: | -3,521,323 |
| # New Positions: | 16 |
| # Closed Positions: | 16 |
| # Increased Positions: | 59 |
| # Reduced Positions: | 46 |
| # Net Buyers: | 13 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Harold Selick |
58 | Chief Executive Officer, Director | |
Stewart Kroll |
54 | 2011 | Senior Vice President - Biostatistics and Clinical Operations |
Mark Matteucci |
59 | 2007 | Senior Vice President - Discovery Research |
Joel Fernandes |
43 | 2011 | Vice President - Finance, Controller |
Tillman Pearce |
56 | 2012 | Chief Medical Officer |
Jeffrey Bird |
52 | 2008 | Independent Director |
Bruce Cozadd |
49 | 2005 | Independent Director |
David Hoffmann |
68 | 2007 | Independent Director |
Wilfred Jaeger |
57 | 2001 | Independent Director |
George Parker |
74 | 2004 | Independent Director |
David Parkinson |
62 | 2010 | Independent Director |
Laura Hansen |
IR Contact |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
